NYP/Queens wins a clinical research training award of $150,000. The award is part of a state program to advance biomedical research in New York through the training of physicians as clinical researchers. It funds the salary and benefits for one clinical researcher for one year. The researcher will be working with Daniel Skupski, M.D., NYP/Queens Vice Chairman of Obstetrics and Gynecology, on a project titled “Influence of Lactic Acid Chiral Isomers and Metalloproteinases on Cervical Remodeling and Preterm Parturition.”
Holly Andersen Scholar Named. Jaslyn Maurer, a pre-med student, is the Lang Research Center’s third Dr. Holly Anderson Scholar. Ms. Maurer serves as the assistant study coordinator for the Type 2 Diabetes GRADE study, NIH sponsored study of Diabetes treatment, led by Daniel Lorber, M.D., and Phyllis August, M.D. and for the PARAGON Study, a heart failure study led by Todd Kerwin, MD.
Seven awards for research excellence were presented on May 20 during Residents and Fellows Research Day. Winners were chosen from a field of 66 abstracts. Keynote speaker Arturo Casadevall, M.D., Ph.D., gave a fascinating discourse on the effect of global warming on fungal thermal tolerance and, as a result, the rise of invasive fungal diseases as a major medical problem.
GRADE Study. (Glycemia Reduction Approaches in Diabetes) Do you have type 2 diabetes? Help to find the best long-term treatment for people with diabetes. Most people with diabetes need metformin and another drug to keep blood sugar close to normal. We are comparing four potential second line treatments in the GRADE study to determine which one, when added to metformin, is best for controlling diabetes. All four treatments are recommended by the American Diabetes Association and FDA approved. Visit https://grade.bsc.gwu.edu and call 718-670-2914, or 718-670-1827.
The Theresa and Eugene M. Lang Center for Research and Education has joined the Maternal-Fetal Medicine Units Network with Columbia University Medical Center, one of 14 clinical centers in the network.
The network conducts clinical studies to improve maternal, fetal and neonatal health with an emphasis on randomized-controlled trials. The goal is to reduce maternal, fetal and infant morbidity related to preterm birth, fetal growth abnormalities and maternal complications as well as to provide insight on evidence-based, cost-effective obstetric practice
Our researchers are making news. Look here for their latest professional accomplishments and activities.